EMEA-001529-PIP02-14-M03

Table of contents

Key facts

Active substance
Testosterone
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0508/2020
PIP number
EMEA-001529-PIP02-14-M03
Pharmaceutical form(s)
Nasal gel
Condition(s) / indication(s)
Treatment of male hypogonadism
Route(s) of administration
Nasal use
Contact for public enquiries
Acerus Biopharma Inc.

Email: fholagh@aceruspharma.com    
Tel. +1 9058178195
 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating